Download PDF
Thromb Haemost 2001; 85(03): 574-576
DOI: 10.1055/s-0037-1615632
Letters to the Editor
Schattauer GmbH

Acute Local Release of Fibroblast Growth Factor-2 but not Transforming Growth Factor-β1 following Coronary Stenting

Harry C. Lowe
1   Centre for Thrombosis and Vascular Research at The University of New South Wales, Sydney, Australia, Department of Haematology, The Prince of Wales Hospital
2   Department of Cardiology, Liverpool Hospital, Sydney, Australia
,
Colin N. Chesterman
1   Centre for Thrombosis and Vascular Research at The University of New South Wales, Sydney, Australia, Department of Haematology, The Prince of Wales Hospital
,
Andrew P. Hopkins
2   Department of Cardiology, Liverpool Hospital, Sydney, Australia
,
Craig P. Juergens
2   Department of Cardiology, Liverpool Hospital, Sydney, Australia
,
Levon M. Khachigian
1   Centre for Thrombosis and Vascular Research at The University of New South Wales, Sydney, Australia, Department of Haematology, The Prince of Wales Hospital
› Author Affiliations
Further Information

Publication History

Received 11 September 2000

Accepted after revision 16 October 2000

Publication Date:
08 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Falciani M, Gori AM, Giusti B, Fedi S, Capanni M, Simonetti I, Margheri M, Prisco D, Abbate R, Gensini GF. Percutaneous Transluminal Coronary Angioplasty procedure is associated to a decrease in transforming growth factor beta 1 levels. Thromb Haemost 1999; 82: 1204-5.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Brogi E, Winkles JA, Underwood R, Clinton SK, Alberts GF, Libby P. Distinct patterns of expression of fibroblast growth factors and their receptors in human atheroma and nonatherosclerotic arteries. J Clin Invest 1993; 92: 2408-18.
    CrossrefPubMedGoogle Scholar
  • 3 Rasmussen LM, Wolf YG, Ruoslahti E. Vascular smooth muscle cells from injured rat aortas display elevated matrix production associated with transforming growth factor-beta activity. Am J Path 1995; 147: 1041-8.
    PubMedGoogle Scholar
  • 4 Libby P, Tanaka H. The molecular bases of restenosis. Prog Cardio Dis 1997; 40: 97-106.
    PubMedGoogle Scholar
  • 5 McCaffrey TA, Du B, Fu C, Bray PJ, Sanborn T, Deutsch E, Tarazona N, Shaknovitch A, Newman G, Patterson C, Bush HL. The expression of TGF B, receptors in human atherosclerosis: evidence for acquired resistance to apoptosis due to receptor imbalance. J Mol Cell Card 1999; 31: 1627-42.
    CrossrefPubMedGoogle Scholar
  • 6 Taylor AJ, Farb AA, Angello DA, Burwell LR, Virmani R. Proliferative activity in coronary atherectomy tissue. Clinical, histopathologic and immunohistochemical correlates. Chest 1995; 108: 815-20.
    CrossrefPubMedGoogle Scholar
  • 7 Caplice NM, Aroney CN, Bett JHN, Cameron J, Campbell JH, Hoffman N, McEniery PT, West MJ. Growth factors released into the coronary circulation after vascular injury promote proliferation of human vascular smooth muscle cells in culture. J Am Coll Cardiol 1997; 29: 1536-41.
    CrossrefPubMedGoogle Scholar
  • 8 Hasdai D, Holmes DR, Garrett KN, Edwards WD, Lerman A. Mechanical pressure and stretch release endothelin 1 from human athersclerotic coronary arteries in vivo. Circ 1997; 95: 357-62.
    CrossrefPubMedGoogle Scholar
  • 9 Lowe HC, Murray B, Chong BH, Chesterman CN, Khachigian LM. Intra-coronary blood sampling using the multifunction probing catheter does not cause platelet activation. J Invas Cardiol 2000; 12: 144-6.
    PubMedGoogle Scholar
  • 10 Chong BH, Murray B, Berndt MC, Dunlop LC, Brighton T, Chesterman CN. Plasma P-selectin is increased in thrombotic consumptive platelet disorders. Blood 1994; 83: 1535-41.
    PubMedGoogle Scholar
  • 11 Lindner V, Reidy MA. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. PNAS 1991; 88: 3739-43.
    CrossrefPubMedGoogle Scholar
  • 12 Lindner V, Lappi DA, Baird A, Majack RA, Reidy MA. Role of basic fibro-blast growth factor in vascular lesion formation. Circ Res 1991; 68: 106-13.
    CrossrefPubMedGoogle Scholar
  • 13 Kahn JK. Coronary stents: increasing options and indications. Cathet Cardiovasc Diagn 1998; 45: 375.
    CrossrefPubMedGoogle Scholar